# A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal Neuralgia

> **NCT01540630** · PHASE2 · COMPLETED · sponsor: **Biogen** · enrollment: 67 (actual)

## Conditions studied

- Trigeminal Neuralgia

## Interventions

- **DRUG:** CNV1014802
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01540630
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03-31
- **Primary completion:** 2014-03-31
- **Final completion:** 2014-06-30
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2019-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01540630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01540630, "A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal Neuralgia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01540630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*